Keywords: iv, procedure, pain, anesiva, zingo, drugmaker, reported
Less IV procedure pain with Anesiva's Zingo
Article | 05 November 2007
US drugmaker Anesiva has reported positive top-line results from a pivotal Phase III study. The multicenter, randomized, double-blind, 699-patient trial ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
